NEW PLATINUM COMPLEXES IN CLINICAL-TRIALS

被引：69

作者：

LEE, FH ^{[1
]}

CANETTA, R ^{[1
]}

ISSELL, BF ^{[1
]}

LENAZ, L ^{[1
]}

机构：

[1] BRISTOL MYERS CO LABS,CANC RES,POB 657,SYRACUSE,NY 13201

来源：

CANCER TREATMENT REVIEWS | 1983年 / 10卷 / 01期

关键词：

D O I：

10.1016/S0305-7372(83)80031-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：39 / 51

页数：13

共 50 条

[1]

AAPRO MS, 1981, ANN INTERNAL MED, V95, P352

[2] STRUCTURE AND ACTIVITY RELATIONSHIPS OF PLATINUM COMPLEXES WITH ANTI-TUMOUR ACTIVITY [J].

BRADDOCK, PD ;

CONNORS, TA ;

JONES, M ;

KHOKHAR, AR ;

MELZACK, DH ;

TOBE, ML .

CHEMICO-BIOLOGICAL INTERACTIONS, 1975, 11 (03) :145-161

[3]

Bradner W.T., 1980, CISPLATIN, P171

[4] TOXICOLOGY SCREENING IN SMALL ANIMALS [J].

BRADNER, WT ;

SCHURIG, JE .

CANCER TREATMENT REVIEWS, 1981, 8 (02) :93-102

[5] STUDIES OF CROSS-RESISTANCE, SYNERGISTIC COMBINATIONS AND BLOCKING OF ACTIVITY OF PLATINUM DERIVATIVES [J].

BURCHENAL, JH ;

KALAHER, K ;

DEW, K ;

LOKYS, L ;

GALE, G .

BIOCHIMIE, 1978, 60 (09) :961-965

[6]

BURCHENAL JH, 1977, CANCER RES, V37, P3455

[7]

BURCHENAL JH, 1979, P AM ASS CANCER RES, V19, P196

[8]

CALVERT AH, 1982, EARLY CLIN STUDIES C

[9]

CARTER SK, 1978, CANCER CHEMOTH PHARM, V1, P69

[10]

Cleare MJ, 1980, CISPLATIN CURRENT ST, P149

← 1 2 3 4 5 →